Log In
Print
BCIQ
Print
Print this Print this
 

OCR-002

Also known as: L-ornithine phenylacetate (formerly UCL-L1V)

  Manage Alerts
Collapse Summary General Information
Company Ocera Therapeutics Inc.
DescriptionCombination of L-ornithine and phenylbutyrate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today